History
  • No items yet
midpage
Bard Peripheral Vascular, Inc. v. W.L. Gore & Associates, Inc.
670 F.3d 1171
| Fed. Cir. | 2012
Read the full case

Background

  • The case concerns Bard’s patent on a ePTFE vascular graft with a defined internodal distance (6–80 microns) and related graft wall properties.
  • Cooper conceived the invention; Goldfarb independently conceived and reduced to practice later; the Board awarded Goldfarb priority but Bard later prevailed on inurement issues.
  • Interference proceedings (Cooper II) held Goldfarb’s work inures to Cooper’s benefit; Bard sued Gore for infringement of the ’135 patent.
  • The district court awarded Bard enhanced damages, attorneys’ fees, and an ongoing royalty after finding willful infringement and no invalidity on inventorship, anticipation, or written description.
  • This court affirmed, holding substantial evidence supported the jury on noninventorship, no anticipation, no obviousness, valid written description, willful infringement, and the royalty/fees awards.
  • A dissent (Newman, J.) criticized the decision, arguing Goldfarb cannot claim rights to Gore’s material and testing results.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Inventorship of the ’135 patent Gore argues Cooper is a joint inventor Bard argues Goldfarb alone conceived the invention Not joint inventors; substantial evidence supports Bard
Anticipation by Matsumoto Matsumoto does not enable or anticipate Matsumoto anticipates the claims Not anticipated; Matsumoto not enabling; no clear and convincing anticipation
Obviousness over Volder and Matsumoto Invention nonobvious in view of Volder/Matsumoto Claims obvious in light of Volder and Matsumoto Not obvious; Volder alone and in combination with Matsumoto do not render claims obvious
Written description Written description supports claims 20–24, 27 Wall thickness 0.2–0.8 mm required Written description sufficient; wall thickness not essential to invention
Willful infringement and remedies Infringement willful; warranted enhanced damages and ongoing royalty No willful infringement; defenses mischaracterized Willful infringement; enhanced damages, fees, and ongoing royalty upheld

Key Cases Cited

  • Cooper v. Goldfarb, 154 F.3d 1321 (Fed. Cir. 1998) (found Cooper conceived; inurement issues; nonjoint inventorship emphasized)
  • Cooper v. Goldfarb, 240 F.3d 1378 (Fed. Cir. 2001) (Cooper conceived; Goldfarb’s work inures to Cooper’s benefit; later analysis of collaboration)
  • Microsoft Corp. v. i4i Ltd. P'ship, 131 S. Ct. 2238 (2011) (clear and convincing standard for invalidity)
  • Ariad Pharm., Inc. v. Eli Lilly & Co., 598 F.3d 1336 (Fed. Cir. 2010) (written description standard en banc)
  • Seagate Tech., LLC v. Harris Corp., 497 F.3d 1360 (Fed. Cir. 2007) (willfulness and objective considerations for infringement)
Read the full case

Case Details

Case Name: Bard Peripheral Vascular, Inc. v. W.L. Gore & Associates, Inc.
Court Name: Court of Appeals for the Federal Circuit
Date Published: Feb 10, 2012
Citation: 670 F.3d 1171
Docket Number: 2010-1510
Court Abbreviation: Fed. Cir.